Basit öğe kaydını göster

dc.contributor.authorAkhisaroglu, M
dc.contributor.authorUz, T
dc.contributor.authorManev, H
dc.contributor.authorKÜRTÜNCÜ, Murat
dc.date.accessioned2022-02-18T11:01:25Z
dc.date.available2022-02-18T11:01:25Z
dc.date.issued2005
dc.identifier.citationAkhisaroglu M., KÜRTÜNCÜ M., Manev H., Uz T., "Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice", PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, cilt.80, sa.3, ss.371-377, 2005
dc.identifier.issn0091-3057
dc.identifier.otherav_d026f23d-af48-424e-8059-670799d34eb4
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/180354
dc.identifier.urihttps://doi.org/10.1016/j.pbb.2004.11.016
dc.description.abstractDopaminergic drugs, including the D2/D3 agonist quinpirole, produce lasting changes in the brain that lead to altered behavioral responses. The action of these drugs is dosing time-dependent; in fruit flies, behavioral response to quinpirole shows a marked circadian variability. Here we demonstrate diurnal rhythm-dependent variations both in quinpirole-induced locomotor behaviors and in striatal D2 and D3 protein levels in mice. We found opposing diurnal rhythms in striatal D2 and D3 protein levels, resulting in a high D2/D3 ratio during the day and a low D2/D3 ratio at night. Protracted quinpirole treatment differentially altered striatal D2/D3 rhythms depending on the time of injection (i.e., day or night). When quinpirole-induced locomotor activity was analyzed for 90 min, we found hypomotility after the first day or nighttime drug injection. By the seventh injection, daytime quinpirole treatment produced clear hyperactivity while nighttime quinpirole treatment continued to induce a significant initial hypoactivity followed by a hyperactivity period. Our data indicate that quinpirole-induced long-term alterations in the brain include dosing time-dependent changes in dopamine receptor rhythms. Therefore, we propose that diurnal mechanisms, which participate in drug-induced long-term changes in the dopamine system, are important for the development of dopaminergic behaviors. (c) 2004 Elsevier Inc. All rights reserved.
dc.language.isoeng
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectBehavioral Neuroscience
dc.subjectGeneral Neuroscience
dc.subjectNeuroscience (miscellaneous)
dc.subjectSensory Systems
dc.subjectExperimental and Cognitive Psychology
dc.subjectNeuropsychology and Physiological Psychology
dc.subjectHuman-Computer Interaction
dc.subjectSinirbilim ve Davranış
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectSocial Sciences & Humanities
dc.subjectPhysical Sciences
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectPharmacology (medical)
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectNEUROSCIENCES
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectDAVRANIŞ BİLİMLERİ
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectSosyal ve Beşeri Bilimler
dc.subjectDavranış Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectDevelopmental Neuroscience
dc.subjectCellular and Molecular Neuroscience
dc.subjectCognitive Neuroscience
dc.titleDiurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice
dc.typeMakale
dc.relation.journalPHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
dc.contributor.department, ,
dc.identifier.volume80
dc.identifier.issue3
dc.identifier.startpage371
dc.identifier.endpage377
dc.contributor.firstauthorID3373097


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster